Oakville, ON – June 20, 2012. (TSX: PTZ) Pethealth Inc. (“Pethealth” or the “Company”), North America’s leading provider of companion animal RFID technology operating in the United States, Canada, and the United Kingdom and the leading provider of animal management software and related database services to North American animal welfare organisations (“AWOs”) is pleased to announce it has partnered with Velcera, Inc., parent company of FidoPharm, Inc. (“FidoPharm”). This exclusive partnership provides Velcera distribution of PetArmor® flea and tick medications and other FidoPharm products to Pethealth’s extensive network of AWOs using its 24PetWatch microchip programs and nearly 1,800 AWOs licensed with the Company’s PetPoint animal management system operating across the United States. PetArmor is the first EPA-approved generic fipronil flea and tick treatment for both dogs and cats. It contains the #1 veterinarian-recommended active ingredient and in the same concentration as the leading brand competitor, providing the same veterinarian-quality flea and tick protection for approximately half the cost.
The agreement brings together two companies that have already demonstrated a commitment to supporting the mission of AWOs and reducing the operating costs of AWOs throughout the United States. Through the Company’s PetPoint Solutions suite of programs and services, including the cloud-based PetPoint animal management system, 24PetWatch microchip and lost pet recovery program, and ShelterCare pet insurance program, its partner AWOs save tens of thousands of dollars on average each year. With the launch of PetArmor and other FidoPharm products, Velcera provides AWOs the ability to significantly reduce the cost of major medications used in their day-to-day activities. The agreement between Pethealth and Velcera runs until December 31, 2013, when both parties will have the option to renew for additional twelve-month periods.
“We are pleased to announce this partnership with Velcera,” said Mark Warren, President and Chief Executive Officer of Pethealth Inc. “The incorporation of the FidoPharm product lines into our growing suite of BtoB offerings to our partner shelters is consistent with our desire to bend the operating cost curve for animal welfare groups and maximise the efficiencies of the PetPoint platform by allowing licensed users to complete all their ordering and manage their inventory through our application.”
In addition, the Company will support the promotion and sale of FidoPharm’s products through its national sales team, call centre operations, and online.
“Our partnership with Pethealth now gives us a platform to effectively distribute important pet health products, including PetArmor for use by animal welfare organisations, which is consistent with our mission of supporting animal welfare organisations that do the important work of care for hundreds of thousands of dogs and cats,” said Dennis Steadman, President and Chief Executive Officer of Velcera, Inc.